key: cord-0897579-xpcmb3tq
authors: Sia, Jacky
title: Dizziness can be an early sole clinical manifestation for COVID‐19 infection: A case report
date: 2020-07-23
journal: J Am Coll Emerg Physicians Open
DOI: 10.1002/emp2.12185
sha: 4b82a35aa9380d3105f6dd53d2ea099264a153cf
doc_id: 897579
cord_uid: xpcmb3tq

SARS‐CoV‐2 is a novel strain of coronavirus that was first identified in Wuhan, China; it has since spread rapidly throughout the world. Most of the patients with COVID‐19 present with respiratory symptoms, including cough, nasal symptoms, fever, and shortness of breath. However, several groups have reported that SARS‐CoV‐2 can infect the central nervous system via the olfactory bulb followed by spread throughout the brain and peripheral nervous system. This brief report illustrated a 78‐year‐old man who presented to the emergency department (ED) on March 22, 2020, with chief complaints of dizziness and unsteadiness while walking. He had no symptoms suggestive of COVID‐19 on arrival. SARS‐CoV‐2 nasopharyngeal swab test performed at that time due to his atypical presentation and lymphocytopenia was positive for virus nucleic acids. The neurological symptoms associated with COVID‐19 are frequently non‐specific and may emerge several days before the respiratory symptoms; as such, identification of patients presenting with these subtle and seemingly unremarkable COVID‐19 symptoms will be quite difficult. Added to this, numerous countries still limit testing for SARS‐COV‐2 to patients presenting with fever or respiratory symptoms. Frontline physicians should be aware of early, non‐specific symptoms associated with SARS‐CoV‐2 infection.

aggressive neurotropic and neuro-invasive capabilities of this virus. 2 Several groups have reported that SARS-CoV-2 has the capacity to infect the central nervous system via the olfactory bulb; from there, it can spread to the brain and peripheral nervous system via a synapseconnected route. 3, 4 In a mouse model, SARS-CoV-2 preferentially infects neurons in the brainstem wherein is the critical factor that regulates cardiopulmonary function; infection at this site may lead to significant cardiopulmonary dysfunction. Infection of the central nervous system may explain some or all of the cardiopulmonary symptoms JACEP Open 2020;1-3.

wileyonlinelibrary.com/journal/emp2 1 2 SIA associated COVID-19 that can be detected when chest radiographs remain relatively clear. 5 In this report, the patient presented with nonspecific neurological symptom few days before his respiratory symptoms appeared. 

Neurological symptoms caused by COVID-19 are diverse and complex (Table 1) . Non-specific symptoms including headache, dizziness, vertigo, and paresthesia have been reported. 6 The most frequent one is SIA 3 anosmia. Some patients develop respiratory symptoms several days (median, 1-2 days) after the emergence of non-specific neurological symptoms, including headache and dizziness. 7 SARS-CoV-2 may use a variety of pathophysiological mechanisms to induce central nervous system dysfunction, including direct invasion, hypoxic insult, hypercoagulopathy, and immune-mediated injury. 3 Avulaa et al reported 4 cases of acute stroke associated with COVID-19. 8 According to Li et al, the incidence of this complication is ∼5% at a median age of 71.6 years. 5 It is postulated that SARS-CoV-2 may cause vascular endothelial dysfunction via mechanisms that include hypoxic insult and a hypercoagulable state, both of which encourage the formation of thromboemolism. 1, 9 These pathophysiological mechanisms lead to acute ischemic stroke, pulmonary emboli, or acute myocardial infarction even in the absence of respiratory symptoms. 1, [9] [10] [11] To conclude, emergency physicians should be vigilant, especially when elderly patients present with non-specific symptoms and unexplained lymphocytopenia.

None.

Jacky Sia MD, MSc.SEM https://orcid.org/0000-0002-3319-0686

COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up

Central nervous system manifestations of COVID-19: a systematic review

Nervous system involvement after infection with COVID-19 and other coronaviruses

Clinical characteristics of coronavirus disease 2019 in China

The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients

Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China

Acuteonset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study

COVID-19 presenting as stroke

Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability

Potential effects of coronaviruses on the cardiovascular system a review

Acute pulmonary embolism and COVID-19 pneumonia: a random association?

Large-vessel stroke as a presenting feature of covid-19 in the young

A first case of meningitis/encephalitis associated with SARS-Coronavirus-2

Neurologic features in severe SARS-CoV-2 infection

Focal status epilepticus as unique clinical feature of COVID-19: a case report

How to cite this article: Sia J. Dizziness can be an early sole clinical manifestation for COVID-19 infection: A case report